Patents by Inventor Il'ya Yadigerovich Bozo

Il'ya Yadigerovich Bozo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9730959
    Abstract: Provided is a biocomposite including cells, a genetic construction, and a scaffold and a method for repairing tissue and organs in mammalians with the biocomposite. The interaction of the components of the biocomposite provides a complex effect on reparative regeneration processes. Also provided is a method for administration of gene-cellular therapeutic constructions to a recipient which can be used in medicine and veterinary to provide reparative processes. After administering the biocomposite to a recipient, the scaffold structure releases the nucleic acids which enter into the cells of a recipient bed and cells of the transplanted product. The nucleic acids are expressed, which results in the increased concentration of a target product responsible for reparative processes.
    Type: Grant
    Filed: December 24, 2012
    Date of Patent: August 15, 2017
    Assignee: “NEXTGEN” COMPANY LIMITED
    Inventors: Artur Aleksandrovich Isaev, Sergej L'vovich Kiselev, Roman Vadimovich Deev, Il'ya Yadigerovich Bozo, Elena Sergeevna Filonenko
  • Publication number: 20140341870
    Abstract: Provided is a biocomposite including cells, a genetic construction, and a scaffold and a method for repairing tissue and organs in mammalians with the biocomposite. The interaction of the components of the biocomposite provides a complex effect on reparative regeneration processes. Also provided is a method for administration of gene-cellular therapeutic constructions to a recipient which can be used in medicine and veterinary to provide reparative processes. After administering the biocomposite to a recipient, the scaffold structure releases the nucleic acids which enter into the cells of a recipient bed and cells of the transplanted product. The nucleic acids are expressed, which results in the increased concentration of a target product responsible for reparative processes.
    Type: Application
    Filed: December 24, 2012
    Publication date: November 20, 2014
    Applicant: "NEXTGEN" COMPANY LIMITED
    Inventors: Artur Aleksandrovich Isaev, Sergej L'vovich Kiselev, Roman Vadimovich Deev, Il'ya Yadigerovich Bozo, Elena Sergeevna Filonenko